220 related articles for article (PubMed ID: 12379549)
1. Randomized controlled economic evaluation of asthma self-management in primary health care.
Schermer TR; Thoonen BP; van den Boom G; Akkermans RP; Grol RP; Folgering HT; van Weel C; van Schayck CP
Am J Respir Crit Care Med; 2002 Oct; 166(8):1062-72. PubMed ID: 12379549
[TBL] [Abstract][Full Text] [Related]
2. Long-term economic evaluation of intensive patient education during the first treatment year in newly diagnosed adult asthma.
Kauppinen R; Vilkka V; Sintonen H; Klaukka T; Tukiainen H
Respir Med; 2001 Jan; 95(1):56-63. PubMed ID: 11207019
[TBL] [Abstract][Full Text] [Related]
3. A cost-effectiveness analysis of a peak flow-based asthma education and self-management plan in a high-cost population.
de Asis ML; Greene R
J Asthma; 2004 Aug; 41(5):559-65. PubMed ID: 15360065
[TBL] [Abstract][Full Text] [Related]
4. Economic evaluation of a brief education, self-management and upper limb exercise training in people with rheumatoid arthritis (EXTRA) programme: a trial-based analysis.
Manning VL; Kaambwa B; Ratcliffe J; Scott DL; Choy E; Hurley MV; Bearne LM
Rheumatology (Oxford); 2015 Feb; 54(2):302-9. PubMed ID: 25173349
[TBL] [Abstract][Full Text] [Related]
5. An economic evaluation of budesonide/formoterol for maintenance and reliever treatment in asthma in general practice.
Goossens LM; Riemersma RA; Postma DS; van der Molen T; Rutten-van Mölken MP
Adv Ther; 2009 Sep; 26(9):872-85. PubMed ID: 19768640
[TBL] [Abstract][Full Text] [Related]
6. Cost-utility analysis of osteopathy in primary care: results from a pragmatic randomized controlled trial.
Williams NH; Edwards RT; Linck P; Muntz R; Hibbs R; Wilkinson C; Russell I; Russell D; Hounsome B
Fam Pract; 2004 Dec; 21(6):643-50. PubMed ID: 15531626
[TBL] [Abstract][Full Text] [Related]
7. E-health in caring for patients with atopic dermatitis: a randomized controlled cost-effectiveness study of internet-guided monitoring and online self-management training.
van Os-Medendorp H; Koffijberg H; Eland-de Kok PC; van der Zalm A; de Bruin-Weller MS; Pasmans SG; Ros WJ; Thio HB; Knol MJ; Bruijnzeel-Koomen CA
Br J Dermatol; 2012 May; 166(5):1060-8. PubMed ID: 22268960
[TBL] [Abstract][Full Text] [Related]
8. Cost-effectiveness of involving nurse specialists for adult patients with urinary incontinence in primary care compared to care-as-usual: an economic evaluation alongside a pragmatic randomized controlled trial.
Albers-Heitner CP; Joore MA; Winkens RA; Lagro-Janssen AL; Severens JL; Berghmans LC
Neurourol Urodyn; 2012 Apr; 31(4):526-34. PubMed ID: 22275126
[TBL] [Abstract][Full Text] [Related]
9. Cost-effectiveness of early intervention with once-daily budesonide in children with mild persistent asthma: results from the START study.
Weiss K; Buxton M; Andersson FL; Lamm CJ; Liljas B; Sullivan SD
Pediatr Allergy Immunol; 2006 May; 17 Suppl 17():21-7. PubMed ID: 16573705
[TBL] [Abstract][Full Text] [Related]
10. Cost-effectiveness of a psychoeducational relapse prevention program for depression in primary care.
Stant AD; TenVergert EM; Kluiter H; Conradi HJ; Smit A; Ormel J
J Ment Health Policy Econ; 2009 Dec; 12(4):195-204. PubMed ID: 20195007
[TBL] [Abstract][Full Text] [Related]
11. Is self-care a cost-effective use of resources? Evidence from a randomized trial in inflammatory bowel disease.
Richardson G; Sculpher M; Kennedy A; Nelson E; Reeves D; Roberts C; Robinson A; Rogers A; Thompson D
J Health Serv Res Policy; 2006 Oct; 11(4):225-30. PubMed ID: 17018196
[TBL] [Abstract][Full Text] [Related]
12. A randomized, controlled study to evaluate the role of an in-home asthma disease management program provided by respiratory therapists in improving outcomes and reducing the cost of care.
Shelledy DC; Legrand TS; Gardner DD; Peters JI
J Asthma; 2009 Mar; 46(2):194-201. PubMed ID: 19253130
[TBL] [Abstract][Full Text] [Related]
13. A multisite randomized trial of the effects of physician education and organizational change in chronic asthma care: cost-effectiveness analysis of the Pediatric Asthma Care Patient Outcomes Research Team II (PAC-PORT II).
Sullivan SD; Lee TA; Blough DK; Finkelstein JA; Lozano P; Inui TS; Fuhlbrigge AL; Carey VJ; Wagner E; Weiss KB
Arch Pediatr Adolesc Med; 2005 May; 159(5):428-34. PubMed ID: 15867115
[TBL] [Abstract][Full Text] [Related]
14. Community or patient preferences for cost-effectiveness of cardiac rehabilitation: does it matter?
Oldridge N; Furlong W; Perkins A; Feeny D; Torrance GW
Eur J Cardiovasc Prev Rehabil; 2008 Oct; 15(5):608-15. PubMed ID: 18800005
[TBL] [Abstract][Full Text] [Related]
15. A 12-week, multicenter, randomized, partially blinded, active-controlled, parallel-group study of budesonide inhalation suspension in adolescents and adults with moderate to severe persistent asthma previously receiving inhaled corticosteroids with a metered-dose or dry powder inhaler.
Murphy K; Noonan M; Silkoff PE; Uryniak T
Clin Ther; 2007 Jun; 29(6):1013-26. PubMed ID: 17692718
[TBL] [Abstract][Full Text] [Related]
16. A multisite randomized trial of the effects of physician education and organizational change in chronic-asthma care: health outcomes of the Pediatric Asthma Care Patient Outcomes Research Team II Study.
Lozano P; Finkelstein JA; Carey VJ; Wagner EH; Inui TS; Fuhlbrigge AL; Soumerai SB; Sullivan SD; Weiss ST; Weiss KB
Arch Pediatr Adolesc Med; 2004 Sep; 158(9):875-83. PubMed ID: 15351753
[TBL] [Abstract][Full Text] [Related]
17. The costs and consequences of omalizumab in uncontrolled asthma from a USA payer perspective.
Campbell JD; Spackman DE; Sullivan SD
Allergy; 2010 Sep; 65(9):1141-8. PubMed ID: 20148804
[TBL] [Abstract][Full Text] [Related]
18. Economic evaluation of a randomized trial comparing Helicobacter pylori test-and-treat and prompt endoscopy strategies for managing dyspepsia in a primary-care setting.
Klok RM; Arents NL; de Vries R; Thijs JC; Brouwers JR; Kleibeuker JH; Postma MJ
Clin Ther; 2005 Oct; 27(10):1647-57. PubMed ID: 16330302
[TBL] [Abstract][Full Text] [Related]
19. Cost-effectiveness analysis of early intervention with budesonide in mild persistent asthma.
Sullivan SD; Buxton M; Andersson LF; Lamm CJ; Liljas B; Chen YZ; Pauwels RA; Weiss KB
J Allergy Clin Immunol; 2003 Dec; 112(6):1229-36. PubMed ID: 14657888
[TBL] [Abstract][Full Text] [Related]
20. Cost-utility of a disease management program for patients with asthma.
Steuten L; Palmer S; Vrijhoef B; van Merode F; Spreeuwenberg C; Severens H
Int J Technol Assess Health Care; 2007; 23(2):184-91. PubMed ID: 17493304
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
